Today: 9 June 2026
Browse Category

NSE:BAJAJHFL 2 December 2025 - 22 December 2025

Bajaj Housing Finance Expansion Buzz, Innovative Tyres Heatmap Alert, and Binani Industries “Momentum Reversal”: Indian Stocks in Focus on December 22, 2025

Bajaj Housing Finance Expansion Buzz, Innovative Tyres Heatmap Alert, and Binani Industries “Momentum Reversal”: Indian Stocks in Focus on December 22, 2025

Bajaj Housing Finance shares traded near ₹96 on Dec. 22, 2025, after recent volatility tied to promoter stake sales and expansion beyond prime mortgages. The stock dropped over 9% on Dec. 2 as block deals hit the market. Investors remain focused on ongoing stake reduction required by public shareholding rules. Competitive pressure in premium housing loans has slowed profit growth.
Bajaj Housing Finance Share Price Near Record Low After Promoter Stake Sale – What Next for NSE: BAJAJHFL?

Bajaj Housing Finance Share Price Near Record Low After Promoter Stake Sale – What Next for NSE: BAJAJHFL?

Bajaj Housing Finance shares traded near ₹94 on 8 December 2025, close to their 52-week low after a 2% promoter stake sale triggered heavy selling. The stock has dropped about 35% over the past year, underperforming sector peers despite continued growth in loans and profits. Bajaj Finance’s holding fell to 86.7% after the block deal. The shares remain above their September 2024 IPO price.
8 December 2025
Bajaj Housing Finance Share Price Crashes 9% After Promoter Stake Sale: What Investors Should Know Now

Bajaj Housing Finance Share Price Crashes 9% After Promoter Stake Sale: What Investors Should Know Now

Bajaj Housing Finance shares plunged about 9% to a record low of ₹94.90 on December 2 after a large promoter stake sale via block deals. Around 19.5–21.77 crore shares, or up to 2.5% of equity, changed hands at prices near ₹95–97, with trading volume far above normal. The sell-off followed Bajaj Finance’s move to reduce its stake to meet minimum public shareholding norms. Broader markets saw only modest declines.

Stock Market Today

  • Eli Lilly Shares Rise Premarket on Successful Late-Stage Weight Loss Trial
    June 8, 2026, 7:25 PM EDT. Eli Lilly's shares rose in premarket trading following positive results from a late-stage trial of retatrutide, a drug designed for weight loss. The trial demonstrated the drug's effectiveness not only in reducing weight but also in alleviating conditions linked to obesity, highlighting potential new treatment options in the growing obesity market.

Latest articles

Mingteng Stock Jumps 81% After Halting $100M Share Sale Plan

Mingteng Stock Jumps 81% After Halting $100M Share Sale Plan

9 June 2026
Mingteng International shares soared 81.3% to $1.94 after the company ended its at-the-market stock sale plan, having raised about $20.6 million in gross proceeds; trading volume hit 24.2 million, dwarfing its $12 million market value, as the move outpaced gains in other U.S.-listed China auto stocks.
Peso Rebounds, But Mexico’s Next Inflation Print Looms

Peso Rebounds, But Mexico’s Next Inflation Print Looms

9 June 2026
Mexico’s peso edged up 0.09% to 17.4644 per dollar after Iran and Israel paused attacks, but traders turned cautious ahead of Tuesday’s Mexico inflation data, which could shape Banxico rate expectations and impact the peso’s yield advantage that has supported the currency.
T1 Energy Shares Dip After KORE Power Files New Update

T1 Energy Shares Dip After KORE Power Files New Update

9 June 2026
T1 Energy shares slid 3.2% to $9.13 after a new SEC filing revealed up to $24.7 million in stock-linked payments for its $32 million KORE Power acquisition, spotlighting dilution risks as the company expands into battery storage and data-center power; the deal’s structure and timing come as T1 seeks growth funding and investors weigh near-term costs against future EBITDA targets.
Go toTop